Sequoia's Dual-Price Equity: One Valuation, Two Truths

Sequoia Capital, the firm that has spent decades lecturing founders on operational rigor and financial integrity, stands accused by Mercor's Brendan Foody of engaging in "dual-pricing"—a practice wherein the same equity is sold at materially different valuations depending on which pocket the investor happens to be holding. This isn't an accounting nuance or a timing discrepancy; this is the financial equivalent of selling the same car to two buyers while insisting each paid the fair market price. For a firm that built its reputation on being the smartest person in the room, Sequoia has managed to become the embodiment of a strategy that would get a Series A startup laughed out of Sand Hill Road.

The accusation carries particular sting because it exposes a fundamental arbitrage that sits at the heart of modern venture capitalism: the ability to manufacture value through opaque pricing mechanisms. When a founder tries to convince one investor that their company is worth $100 million while telling another investor the same company is worth $75 million, we call it fraud. When Sequoia does it, we call it "portfolio optimization." The dual-pricing scheme works because limited partners and founders rarely cross-reference valuations, and because the venture industry operates in an information asymmetry so vast it makes insider trading look like a fair fight. Foody's willingness to name names and call out the practice suggests someone finally got tired of pretending that the emperor's clothes are real.

This isn't Sequoia's first rodeo with questionable valuation mechanics, nor will it be the last. The VC industry has spent the better part of two decades perfecting the art of marking assets up until they're theoretically worth more than the GDP of small nations, only to mark them down with equal enthusiasm when distributions become inconvenient. Sequoia has been a willing participant in this cycle, which makes the accusation of dual-pricing less of a scandal and more of a logical endpoint: when you've already justified every other valuation fiction, why not just sell the same stock at two different prices and call it a day?

The mechanism is almost elegant in its audacity. By selling identical equity stakes at different prices to different investors, a firm can optimize returns across its portfolio while maintaining the fiction that each transaction reflects arm's-length market pricing. It's the kind of move that requires a team of lawyers to explain why it's technically legal, which is always a warning sign that the practice sits in a dangerous gray zone between clever structuring and outright deception. The buzzwords are already forming in our minds: "liquidity optimization," "strategic pricing tiers," "investor-class differentiation." Translation: we got caught charging different prices and need fancy language to explain it.

The danger here extends beyond Sequoia's reputation—though that's already looking pretty scuffed. When the industry's most prestigious firm openly engages in valuation gymnastics, it creates cascading incentives for every other player to do the same. Limited partners will demand answers about whether their capital was priced at a discount to some other investor's identical stake. Founders will start asking uncomfortable questions about whether the valuations they received were genuine reflections of market sentiment or just Sequoia's internal spreadsheet calculations. And the entire venture capital thesis—that rigorous capital allocation drives efficient markets—collapses under the weight of its own contradiction.

What makes Foody's accusation so damaging is that it forces the industry to confront something it has spent decades avoiding: venture capital pricing is not a science, it is a performance art form. Sequoia didn't invent dual-pricing, but being caught practicing it reveals the gap between the sector's self-image as rational allocators of capital and its actual function as a mechanism for extracting asymmetric returns through information control. If the smartest money in the room is selling the same equity at two different prices, then perhaps the smartest money isn't quite as smart as everyone pretended.